Macromoltek Inc

company

About

Macromoltek does computational drug discovery for pharma companies, focusing on antibodies for therapeutics and diagnostics.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$178.70K
Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

Macromoltek does computational drug discovery for pharma companies, focusing on antibodies for therapeutics and diagnostics. This mother-daughter team’s approach aims to make research for everything from flu to cancer treatments an order of magnitude faster. With an accelerated process to discover antibodies, medical researchers can (1) craft targeted treatment plans for previously undruggable targets and (2) overcome patients’ drug resistance, a major challenge when treating diseases caused by bacteria, viruses, and parasites.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.37M
Macromoltek Inc has raised a total of $1.37M in funding over 2 rounds. Their latest funding was raised on Aug 20, 2016 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 20, 2016 Grant $1.19M 1 National Science Foundation Detail
Jun 15, 2015 Grant $178.70K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Macromoltek Inc is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant